CBT insiders

20 insiders have filed at CBT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Keohane Sean DPresident And CEO418.1k0.801%8 sells $13.2M
Zhu Jeff JiExecutive Vice President85.3k0.163%7 sells $7.6M
Mclaughlin EricaExecutive Vice President, CFO77.8k0.149%18 sells $8.1M
Kalkstein HobartExecutive Vice President60.3k0.116%11 sells $11.7M
Kalita Karen ASVP And General Counsel45.8k0.088%2 sells $3.2M
Enriquez Cabot JuanDirector41.5k0.08%
Kirby William C.Director27.7k0.053%
Rataj Sue H.Director27.5k0.053%
Morrow Michael MDirector22.3k0.043%
Wolfgruber Matthais L.Director22.1k0.042%
Arnold Cynthia ADirector19.6k0.038%
Wilson Frank AndersDirector18.6k0.036%
Yan Christine YDirector17.2k0.033%
Delgrosso Douglas GDirector15.1k0.029%
Wood Matthew ForsterSenior Vice President13.5k0.026%
Dumont Lisa MVP, Controller & CAO13.3k0.026%1 sells $97k
Nathoo RaffiqDirector9.3k0.018%
Masterson William F IIISenior Vice President7.2k0.014%
Williams Michelle ElizabethDirector6.8k0.013%
Vanlancker Thierry FjDirector4.9k<0.01%

Full register at boothcheck.com/insiders/CBT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

CBT institutional holders · CBT research report